Alex Chehrazi‐Raffle
Papers
1
Total Citations
1
H-Index
1
About
Dr. Alex Chehrazi‐Raffle is a leading oncologist and researcher whose work centers on improving outcomes for patients with genitourinary malignancies, particularly bladder and kidney cancers. A key focus of his research is refining treatment strategies for muscle-invasive bladder cancer (MIBC) by addressing critical staging inaccuracies. In his highly cited work, Dr. Chehrazi‐Raffle investigated clinical predictors and prognostic significance of pathologic disease upstaging at radical cystectomy, stratifying patients by neoadjuvant chemotherapy (NAC) receipt. This research, which has garnered significant attention in the urologic oncology community, provides essential insights for optimizing surgical and perioperative decision-making. By identifying which patients are at highest risk for upstaging, his findings help clinicians tailor more effective, personalized treatment plans—potentially reducing both undertreatment and overtreatment. Dr. Chehrazi‐Raffle’s contributions are shaping the standard of care in bladder cancer management, and his ongoing work continues to influence how we approach complex staging challenges in MIBC. His research is widely cited and respected, underscoring his impact on the field.
Research Focus
Key Achievements
Top Papers
- 1